HIGHLIGHTS
- who: Lin Zhao from the Center for Healthy Aging, Changzhi Medical College, Changzhi, Shanxi, China Key Laboratory of Esophageal Cancer Basic Research and Clinical Transformation, Heping have published the paper: Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer, in the Journal: (JOURNAL) of 29/01/2022
- what: A Randomized Clinical Trial was conducted to investigate the lowering of arginine--the arginine-lowering agent pegylated arginine deiminase (ADI-PEG20) arginine deprivation can prolong the survival of patients with advanced ASS1-deficient malignant pleural mesothelioma .
- how: Experimental results showed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.